Laparoscopic-assisted microwave ablation in treatment of small hepatocellular carcinoma: safety and efficacy in comparison with laparoscopic hepatectomy

Youping Wei,Lihong Zhang,Shun Zhang,Meina Song,Changhui Ji

DOI: https://doi.org/10.1186/s12893-024-02432-0

2024-05-09

BMC Surgery

Abstract:Laparoscopic-assisted microwave ablation (LAMWA), as one of the locoregional therapies, has been employed to treat hepatocellular carcinoma (HCC). This study aims to compare the efficacy and safety of LAMWA and laparoscopic hepatectomy in the treatment of small HCC.This study included 140 patients who met the inclusion criteria. Among them, 68 patients received LAMWA and 72 patients underwent laparoscopic hepatectomy. The perioperative condition, liver function recovery, the alpha fetoprotein (AFP) level, morbidities, hospitalization time, overall survival (OS), disease-free survival (DFS) and recurrence rate between the two groups were compared. The rate of complete elimination of tumor tissue was 100% and the AFP level was returned to normal within 3 months after surgery in both groups ( P > 0.05). The mean alanine transaminase (ALT) and aspartate transaminase (AST) peak in the LAMWA group was lower than that in the laparoscopic hepatectomy group (259.51 ± 188.75 VS 388.9 ± 173.65, P = 0.000) and (267.34 ± 190.65 VS 393.1 ± 185.67, P = 0.000), respectively. The mean operation time in the LAMWA group was shorter than that in the laparoscopic hepatectomy group (89 ± 31 min VS 259 ± 48 min, P = 0.000). The blood loss in the LAMWA group was less than that in the laparoscopic hepatectomy group (58.4 ± 64.0 ml VS 213.0 ± 108.2 ml, P = 0.000). Compared with the laparoscopic hepatectomy group, patients in the LAMWA group had lower mean hospital stay (4.8 ± 1.2d VS 11.5 ± 2.9d, P = 0.000). The morbidities of the LAMWA group and the hepatectomy group were 14.7%(10/68) and 34.7%(25/72), respectively ( P = 0.006). The one-, three-, and five-year OS rates were 88.2%, 69.9%, 45.6% for the LAMWA group and 86.1%, 72.9%, 51.4% for the laparoscopic hepatectomy group ( P = 0.693). The corresponding DFS rates for the two groups were 76.3%, 48.1%, 27.9% and 73.2%, 56.7%, 32.0% ( P = 0.958). Laparoscopic-assisted microwave ablation is a safe and effective therapeutic option for selected small HCC.

surgery

What problem does this paper attempt to address?

This paper aims to compare the efficacy and safety of laparoscopic - assisted microwave ablation (LAMWA) and laparoscopic hepatectomy in the treatment of small hepatocellular carcinoma (HCC). Specifically, the researchers hope to evaluate whether LAMWA can be a safe and effective treatment option by comparing the differences between the two treatment methods in terms of operation time, blood loss, complication rate, hospital stay, liver function recovery, overall survival rate (OS), disease - free survival rate (DFS) and recurrence rate, especially for those small HCC patients who are not suitable for traditional hepatectomy.

### Main research questions:
1. **Operation time and blood loss**: Does LAMWA have a shorter operation time and less blood loss compared with laparoscopic hepatectomy?
2. **Complications and hospital stay**: Can LAMWA reduce the incidence of postoperative complications and shorten the patient's hospital stay?
3. **Liver function recovery**: Is the impact of LAMWA on postoperative liver function less than that of laparoscopic hepatectomy?
4. **Long - term efficacy**: Are the overall survival rate (OS), disease - free survival rate (DFS) and recurrence rate of LAMWA at 1 year, 3 years and 5 years equivalent to those of laparoscopic hepatectomy?

### Research methods:
- **Research design**: Retrospective analysis
- **Sample size**: A total of 140 patients who met the inclusion criteria were included, among which 68 received LAMWA and 72 received laparoscopic hepatectomy.
- **Data collection**: Record the peri - operative conditions, liver function recovery, complications, hospital stay, overall survival rate (OS), disease - free survival rate (DFS) and recurrence rate of the two groups of patients.
- **Statistical analysis**: Use SPSS software for data analysis. For continuous variables, t - test or Mann - Whitney U test is used; for categorical variables, chi - square test or Fisher's exact test is used; survival curves are drawn by Kaplan - Meier method and compared by log - rank test.

### Conclusion:
The research results show that LAMWA is superior to laparoscopic hepatectomy in terms of operation time, blood loss, complication rate, liver function recovery and hospital stay. In terms of long - term efficacy, there is no significant difference between LAMWA and laparoscopic hepatectomy in the overall survival rate (OS), disease - free survival rate (DFS) and recurrence rate at 1 year, 3 years and 5 years. Therefore, LAMWA is a safe and effective treatment option, especially suitable for some specific small HCC patients.